pajamasmedia.com - 12/18/2008
—
DEFEAT MALARIA? Yes we can.
Last week, two studies published in the New England Journal of Medicine reported promising news about a malaria vaccine candidate that our company, GlaxoSmithKline, is developing in collaboration with the Malaria Vaccine Initiative, a program of the nonprofit ...
Comments
Blog Reactions
Environmental Whackjobs Murder Millions of Helpless Children
Daily Pundit —
Instapundit » Blog Archive » DEFEAT MALARIA? Yes we can. Last week, two studies published in the New England Journal of Medic…
The studies focused on the most vulnerable populations in Kenya and Tanzania. One study reported that the vaccine candidate was 53% effective in preventing episodes of clinical malaria in children five to 17 months old.
I mentioned this in passing earlier, but this is potentially huge. Most westerners have no idea what a burden malaria is on large parts of the world, but just imagine how ...
Related Content
New malaria vaccine more than 50 percent effective
blog.foreignpolicy.com 12/9/2008 — Results of the latest malaria vaccine trials will be published today in The New England Journal of Medicine , and from the looks of it, the news is good--fantastic, in fact. "We are closer than every before to having a malaria vaccine for use ...
'Target: Malaria'
corner.nationalreview.com 4/24/2009 — Tomorrow is World Malaria Day. In this morning Wall Street Journal, Peter Chernin, the chairman of Malaria No More, writes about the danger to reduce the funding to fighting malaria -- even in times of economic downturns. He reminds us how murderous ...
Great News
washingtonmonthly.com 12/10/2008 — Great News Wonderful news from the New England Journal of Medicine (1, 2), summarized by FP Passport: Results of the latest malaria vaccine trials will be published today in The New England Journal of Medicine, and from the looks of...
Malaria Vaccine Effective in Latest Trials - US News and World Report
health.usnews.com 12/9/2008 — HealthDay Reporter MONDAY, Dec. 8 (HealthDay News) Results from two phase II trials in Africa show that a new malaria vaccine is effective at preventing both infection and the mosquito-borne disease itself in infants and children."Malaria is killing ...
- Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in Infants
content.nejm.org 12/9/2008 — ABSTRACT Background The RTS,S/AS malaria vaccine is being developed for delivery through the World Health Organization's Expanded Program on Immunization (EPI). We assessed the feasibility of integrating RTS,S/AS02D into a standard EPI schedule for ...
Follow BeltwayBlips on Twitter
